Professor Peter Goadsby elected Fellow of the Royal Society

11th May 2022

We’re thrilled to congratulate Professor Peter Goadsby, Director of the National Institute for Health and Care Research (NIHR)-Wellcome King’s Clinical Research Facility and trustee of The Migraine Trust, who has been elected to the Fellowship of the prestigious Royal Society.

The Royal Society is a fellowship made up of the most eminent scientists, engineers and technologists from the UK and the Commonwealth, and includes 85 Nobel Laureates.

With a career spanning four decades, Professor Goadsby is a world-leading researcher in the field of migraine and cluster headache. His work has not only helped us understand the mechanisms behind migraine and other headache conditions, it has also created exciting new treatment options for the one in seven people living with migraine.

Professor Goadsby’s pioneering research led to the development of calcitonin gene-related peptide monoclonal antibody (CGRP mAb) treatments for migraine, which many people have described as life-changing. Last year Professor Goadsby, alongside three fellow researchers, was awarded the highly prestigious Brain Prize in recognition of their discovery of the role of CGRP in migraine.

“This is an amazing honour that has only happened with the help of many patients, collaborators, colleagues and students with whom I have worked. I am deeply grateful to everyone, and so pleased to be part of headache science coming of age and improving patients' lives.”

Professor Peter Goadsby, Professor of Neurology at King’s College London and trustee of The Migraine Trust

“I’d like to extend many congratulations to Peter for his election to the Royal Society, which is so well deserved. It is a true honour and privilege to have him as a trustee and to be able to work with him. On behalf of the 10 million people in the UK with migraine, we thank Peter for his tireless work to help those living with this debilitating and often overlooked condition. His research has drastically improved so many people’s lives and will no doubt benefit many more in years to come.”

Rob Music, Chief Executive of The Migraine Trust